Activest Wealth Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Activest Wealth Management’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-939	Closed	-$2K	–	633
2022 Q2	$2K	Hold	939	–	–	﹤0.01%	346
2022 Q1	$3K	Hold	939	–	–	﹤0.01%	292
2021 Q4	$4K	Hold	939	–	–	﹤0.01%	278
2021 Q3	$5K	Hold	939	–	–	﹤0.01%	296
2021 Q2	$6K	Hold	939	–	–	﹤0.01%	253
2021 Q1	$7K	Buy	+939	New	+$6.76K	0.01%	222

Other funds holding PRTK

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

1CM

1492 Capital Management Milwaukee, Wisconsin $263M AUM 61.9% 1-Year Est. Return

Activest Wealth Management's PRTK Position: Q3 2022 in Review

Activest Wealth Management sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2022, closing a stake of 939 shares — an estimated $2K sold.

Activest Wealth Management first reported a position in PRTK in Q1 2021 and held it in 6 quarters. The position peaked at $7K in Q1 2021. 72 funds tracked by Wall St. Rank hold PRTK as of Q3 2022.

Activest Wealth Management reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2022 after selling out during the quarter.
Activest Wealth Management sold 939 Paratek Pharmaceuticals, Inc. shares in Q3 2022, an estimated $2K.
Activest Wealth Management first reported a position in Paratek Pharmaceuticals, Inc. in Q1 2021 and held it in 6 quarters.
Activest Wealth Management's Paratek Pharmaceuticals, Inc. position peaked at $7K in Q1 2021.
72 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2022.

Based on Activest Wealth Management's 13F filing for Q3 2022, filed 13 Oct 2022.